Arvinas Inc (ARVN)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
SIC: | PHARMACEUTICAL PREPARATIONS |
CEO: | John G. Houston |
Employees: | 420 |
Web site: | arvinas.com |
395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
203-535-1456
|
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Arvinas, Inc. engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC)
Please log in first to see chart